Sundrug Co.,Ltd. (TYO:9989)
3,712.00
-5.00 (-0.13%)
Aug 21, 2026, 3:30 PM JST
Sundrug Revenue
Sundrug had revenue of 215.33B JPY in the quarter ending June 30, 2026, with 3.68% growth. This brings the company's revenue in the last twelve months to 850.15B, up 4.32% year-over-year. In the fiscal year ending March 31, 2026, Sundrug had annual revenue of 842.51B with 5.08% growth.
Revenue (ttm)
850.15B
Revenue Growth
+4.32%
P/S Ratio
0.51
Revenue / Employee
114.01M
Employees
7,457
Market Cap
434.24B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 842.51B | 40.70B | 5.08% |
| Mar 31, 2025 | 801.81B | 50.03B | 6.66% |
| Mar 31, 2024 | 751.78B | 61.32B | 8.88% |
| Mar 31, 2023 | 690.46B | 41.73B | 6.43% |
| Mar 31, 2022 | 648.73B | 14.42B | 2.27% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Tsuruha Holdings | 1.81T |
| MatsukiyoCocokara & Co. | 1.13T |
| COSMOS Pharmaceutical | 1.10T |
| Sugi Holdings | 1.04T |
| Ain Holdings | 647.83B |
| Kusuri No Aoki Holdings | 566.87B |
| Create SD Holdings | 497.13B |
| Qol Holdings | 292.95B |